CBX2 and lymphoma: CBX2-depleted samples revealed the downregulation of gene sets mainly related to proliferation, such as E2F and MYC targets, inflammation, and oxidative phosphorylation (Fig. 5B and Supplementary Fig. 2A), which is upregulated in several cancers including leukemia and lymphoma [20, 21].